A new technology has been developed to suppress immune rejection, the biggest challenge in organ transplantation, without causing systemic side effects. A research team from Pohang University of ...

Charles River Laboratories International, Inc. ( CRL) TD Cowen 46th Annual Health Care Conference March 3, 2026 9:50 AM EST ...

Physicians Committee experts expressed support for two recent actions the agency has taken toward implementing the human-based initiative launched in 2025 and made recommendations for building on this ...

Presented positive updated data from the ALLOHA™ Phase 1 heme trial at 67th American Society of Hematology (ASH) Annual Meeting and Exposition ...

Families in Kensington and beyond are grappling with a crisis shaped by migration, disinvestment, and a public health response that many say has failed them.

Ifetroban Clinical Progress -- Phase II FIGHT DMD trial showed high-dose treatment improved LVEF by 3.3% versus placebo and 5.4% over propensity-matched controls, with Fast Track, Orphan Drug, and ...

Players don't receive a lifetime ban until a third PED violation. Perhaps it's time to reconsider the current penalties for ...

Life House University doesn't offer a quick fix, but its approach is changing lives and helping to reunite parents with their ...

It's designed to take the place of complicated, multiple drug regimens that many people with HIV need to follow. And it's ...

Ingestible smart capsules deliver medication directly to specific gut locations using microscopic needles and targeted drug ...